List of Tables
Summary Table: Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, Through 2029
Table 1: People 65 Years and Over, by Development Group, 2023 and 2050
Table 2: People 65 Years or Over, by WHO Region, 2019 and 2050
Table 3: Projected Number of U.S. Adults 50 and Older with More than One Chronic Condition
Table 4: Recent EU-Level Initiatives Addressing Chronic Diseases, 2022
Table 5: Weighted Adherence Rates in India, 2022
Table 6: Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, Through 2029
Table 7: Global Market for Pharmaceutical Drugs and Biologics for Chronic Disease Management, by Region, Through 2029
Table 8: Global Market for Pharmaceutical Drugs and Biologics for Chronic Diseases Management, by Product, Through 2029
Table 9: Recently Approved Pharmaceutical Drugs for Chronic Disease Management, 2024
Table 10: Global Market for Pharmaceutical Drugs in Chronic Disease Management, by Region, Through 2029
Table 11: Recently Approved Biologics for Chronic Disease Management, 2024
Table 12: Global Market for Biologics in Chronic Disease Management, by Region, Through 2029
Table 13: Global Market for Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 14: Global Market for Medical Devices for Chronic Disease Management, by Product Type, Through 2029
Table 15: Global Market for Traditional Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 16: Global Market for Wearable Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 17: Global Market for Digital Therapeutics for Chronic Disease Management, by Region, Through 2029
Table 18: Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Application, Through 2029
Table 19: Cancer Deaths in the U.S., 2024
Table 20: Global Market for Oncology Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 21: Global Market for Metabolic Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 22: Global Market for Cardiovascular Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 23: Global Market for Immunological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 24: Global Market for Respiratory Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 25: Global and Regional Key Findings on Rehabilitation Needs, 2021
Table 26: Global Market for Musculoskeletal Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 27: Global Market for GI Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 28: Global Market for Neurological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 29: Global Market for Psychiatric Diseases Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 30: Global Market for Other Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 31: Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 32: Global Market for Home Care Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 33: Global Market for Therapeutics and Device Technologies in Hospitals and Other Facilities in Chronic Disease Management, by Region, Through 2029
Table 34: Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 35: North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 36: North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 37: North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 38: North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 39: U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 40: U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 41: U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 42: Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 43: Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 44: Canadian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 45: Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 46: Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 47: Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 48: European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 49: European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 50: European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 51: European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 52: U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 53: U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 54: U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 55: French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 56: French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 57: French Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 58: Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 59: Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 60: Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 61: Leading Causes of Disease Burden in Germany, by DALYs (Level 3), 2022
Table 62: German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 63: German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 64: German Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 65: Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 66: Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 67: Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 68: Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 69: Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 70: Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 71: Percentage of Healthcare Professionals who Use Digital Health Technology or Mobile Health Apps, by Country, 2021
Table 72: Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 73: Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 74: Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 75: Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 76: Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 77: Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 78: Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 79: Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 80: Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 81: Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 82: Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 83: Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 84: Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 85: Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 86: Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 87: Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 88: South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 89: South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 90: South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 91: Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 92: Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 93: Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 94: RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product Through 2029
Table 95: RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 96: RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 97: AI-driven Drug Discovery and Development in Cardiology
Table 98: ESG Highlights, by Leading Companies, 2023
Table 99: ESG Risk Ratings for Pharma Firms in the Chronic Disease Management Market, 2023
Table 100: M&A in the Chronic Disease Management Industry, 2021-2024
Table 101: Patent Analysis, by Year, 2021-August 2024
Table 102: Strategic Alliances in the Chronic Disease Management, Therapeutics and Device Technologies Market, 2021-2024
Table 103: Information Sources in This Report
Table 104: Abbreviations Used in This Report
Table 105: Abbott: Company Snapshot
Table 106: Abbott: Financial Performance, FY 2022 and 2023
Table 107: Abbott: Product Portfolio
Table 108: Abbott: News/Key Developments, 2023 and 2024
Table 109: Amgen Inc.: Company Snapshot
Table 110: Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 111: Amgen Inc.: Product Portfolio
Table 112: Amgen Inc.: News/Key Developments, 2021-2024
Table 113: AstraZeneca: Company Snapshot
Table 114: AstraZeneca: Financial Performance, FY 2022 and 2023
Table 115: AstraZeneca: Product Portfolio
Table 116: AstraZeneca: News/Key Developments, 2021-2024
Table 117: Boston Scientific Corp.: Company Snapshot
Table 118: Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 119: Boston Scientific Corp.: Products Portfolio
Table 120: Boston Scientific Corp.: News/Key Developments, 2023 and 2024
Table 121: Bristol-Myers Squibb Co.: Company Snapshot
Table 122: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 123: Bristol-Myers Squibb Co.: Product Portfolio
Table 124: Bristol-Myers Squibb Co.: News/Key Developments, 2021-2024
Table 125: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 126: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 127: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 128: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
Table 129: GSK Plc.: Company Snapshot
Table 130: GSK Plc.: Financial Performance, FY 2022 and 2023
Table 131: GSK Plc.: Product Portfolio
Table 132: GSK Plc.: News/Key Developments, 2024
Table 133: Johnson & Johnson Services Inc.: Company Snapshot
Table 134: Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 135: Johnson & Johnson Services Inc.: Product Portfolio
Table 136: Johnson & Johnson Services Inc.: News/Key Developments, 2022-2024
Table 137: Medtronic: Company Snapshot
Table 138: Medtronic: Financial Performance, FY 2022 and 2023
Table 139: Medtronic: Product Portfolio
Table 140: Medtronic: News/Key Developments, 2022-2024
Table 141: Pfizer Inc.: Company Snapshot
Table 142: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 143: Pfizer Inc.: Product Portfolio
Table 144: Pfizer Inc.: News/Key Developments, 2022-2024
List of Figures
Summary Figure: Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, 2021-2029
Figure 1: Use of Digital Technologies and Data in Patients’ Medicines
Figure 2: Comparison of Drug Approval Processes in the U.S. and EU
Figure 3: Market Dynamics for Therapeutics and Devices for Chronic Disease Management
Figure 4: Share of New Global Cases of Cancer, by Region, 2022
Figure 5: Share of Global Cancer Mortality Cases, by Region, 2022
Figure 6: Frequency of Non-adherence Behaviors, 2020
Figure 7: Global Market Share of Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, 2023
Figure 8: Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by End User, 2023
Figure 9: Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2021-2029
Figure 10: Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2023
Figure 11: Role of AI in Anti-Cancer Drug Development
Figure 12: 2024 Progress Assessment: Tracking Sustainable Development Goals
Figure 13: Share of Patents Published on Chronic Disease Management, by Assignee Country, 2021-2024
Figure 14: Global Market Shares of Chronic Disease Management, Therapeutics and Device Technologies, by Leading Companies, 2023
Figure 15: Abbott: Revenue Share, by Country/Region, FY 2023
Figure 16: Abbott: Revenue Share, by Business Unit, FY 2023
Figure 17: Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 18: Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19: AstraZeneca: Revenue Share, by Country/Region, FY 2023
Figure 20: AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 21: Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 22: Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 23: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 24: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 25: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27: GSK Plc.: Revenue Share, by Country/Region, FY 2023
Figure 28: GSK Plc.: Revenue Share, by Business Unit, FY 2023
Figure 29: Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 31: Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 32: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 33: Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34: Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
